The market sold off Cooper Companies on the day, with the stock dropping about 15%. The decline came even as the medical device group posted Q3 revenue of US$1.066b and basic earnings per share of US$2.24, a sharp swing back into profit after a loss in Q2. The real headline is not the top line. Record free cash flow of US$273m, alongside an 11th straight non generally accepted accounting principles earnings beat, is what investors now need to weigh against the sudden reset in the share price.
Love Cooper Companies’ strong free cash flow but uncomfortable with a 15% price drop on the same day? Check out the 11 resilient stocks with low risk scores for ideas that pair resilient balance sheets with more muted price swings.
